My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Optimi Health Corp (OP:OPTHF)

0.2523 -0.0211 (-7.72%)

Streaming Delayed Price Updated: 11:55 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Optimi Health Corp

< Previous 1 2 3 Next >

Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions ↗

October 20, 2022

Canada is hosting discussions on legal access to psychedelic-assisted therapies, especially after Alberta passed regulatory measures for this type of health s

Via Benzinga

Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson

October 12, 2022

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP-grade psilocybin, synthetic psychedelic substances and...

Via PressReach

Optimi Closes Non-Brokered Private Placement, Here Are The Details ↗

October 11, 2022

Canadian licensed producer of GMP-grade psilocybin Optimi Health Corp.

Via Benzinga

Psychedelic Drugs Prove Their Worth In Clinical Trials

October 11, 2022

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...

Via PressReach

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...

Via PressReach

Topics Cannabis

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

Via FinancialNewsMedia

Topics Cannabis

Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers ↗

September 22, 2022

Health Canada receives applications concerning clinical trials on a regular basis. This time, the licensed producer of natural EU-GMP psilocybin and MDMA Optimi Health Corp.

Via Benzinga

Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA

September 22, 2022

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian company that makes natural, scalable, and easy-to-get psychedelic and functional mushrooms, as well as synthetic formulations, to help people...

Via PressReach

Topics Supply Chain

Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward ↗

September 07, 2022

Expert functional and magic mushrooms grower Optimi Health Corp. (OTCQX: OPTHF) has signed an agreement with Avida Global, a privately-held UK-based producer of white label products including...

Via Benzinga

Psychedelics May Make People Less Afraid of Death

September 07, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change...

Via FinancialNewsMedia

Topics Supply Chain

New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials ↗

September 02, 2022

With psilocybin among the favorites within psychedelics,

Via Benzinga

Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics ↗

September 01, 2022

Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.

Via Benzinga

Psychedelics Use Among Young Adults Reaches All-Time High

September 01, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,...

Via FinancialNewsMedia

First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details ↗

August 30, 2022

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that...

Via Benzinga

Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead ↗

August 16, 2022

Optimi Health Corp.

Via Benzinga

Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients ↗

August 10, 2022

The Canadian-based company licensed by Health Canada for psychedelic and functional mushrooms production, Optimi Health Corp.

Via Benzinga

Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression

August 10, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...

Via FinancialNewsMedia

Topics Supply Chain

What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture ↗

August 08, 2022

Optimi Health Corp.

Via Benzinga

New Optimi Supply Agreement: Psilocybin For Phase 1 Trial On Microdosing For Wellbeing, No Hallucinogenic Effects ↗

July 13, 2022

Canadian psychedelics company Optimi Health Corp. (OTCQX: OPTHF) signed a supply agreement with the Bloom Psychedelic Therapy And Research Centre, a Calgary-based provider of psychedelic-assisted...

Via Benzinga

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details ↗

June 28, 2022

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its...

Via Benzinga

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗

June 15, 2022

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Via Benzinga

Shrooms Move Forward For Palliative Care, Optimi To Supply High-Grade Psilocybin For Private Mental Health Practitioner In CA ↗

June 08, 2022

Optimi Health Corp.

Via Benzinga

Optimi Health Signs Two New Supply Agreements In Less Than a Week ↗

May 31, 2022

Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies.

Via Benzinga

Optimi Completes First Grow of Psilocybin Mushrooms, Introduces New Head Of Cultivation ↗

May 25, 2022

Optimi Health Corp. (OPTHF), the Canadian company that produces homegrown and scalable mushrooms accessible to all, announces big step towards commercialization. It has successfully completed its first...

Via Benzinga

Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗

May 24, 2022

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

Via Benzinga

Optimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank ↗

May 18, 2022

Optimi Health Corp (OTCQX: OPTHF) acquired thirty-three types of psilocybin and mushroom strains intended for cultivation.

Via Benzinga

Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application

October 05, 2021

Company utilizes green chemistry to stabilize natural product with higher yields Vancouver, BC – October 5, 2021 – Optimi Health Corp. (OTCQB: OPTHF) (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”),...

Via FinancialNewsMedia

Topics Intellectual Property

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market

October 05, 2021

Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to...

Via FinancialNewsMedia

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.